One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Microbial Therapeutic Products Market

[ 英語タイトル ] Global Microbial Therapeutic Products Market Size study, by source (bacteria, fungi ), by Application (Metabolic Disorders, Haematological Disorders ,Oncology ,Immunological Disorders) by End User (Hospitals, Pharmaceuticals & Biopharmaceutical Companies, Research & Academic Institutions) and Regional Forecasts 2020-2027


Product Code : BRCLHC00110330
Survey : Bizwit Research & Consulting LLP
Publish On : January, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
Enterprise User USD6250 / Question Form
Amgen Inc.
Merck & Co.,Inc.
Valent BioSciences Corp.
GlaxoSmithKline plc
Pfizer Inc.
bioMérieux SA
Ajinomoto Co.Inc.
Sanofi S.A
Novartis AG
NovaDigm Therapeutics

[Report Description]

Global Microbial Therapeutic market is valued approximately USD 179.28 million in 2019 and is anticipated to grow with a healthy growth rate of more than 8.7 % over the forecast period 2020-2027. A microbe is a microscopic living organism, such as a bacteria, yeast, or fungus. Microbial products are produced by microbes and are mainly utilized for producing cheese, wine , vinegar and bread. Medicinal microbiology includes production of enzymes, antibiotics, nutrients etc. The driving factors for microbial products are increasing prevalence of diseases which has led to the adoption of microbial technology for production of enzymes, vitamins and nutrients. According to the World Health Organization, chronic disease prevalence is slated to increase 57% by 2020-end which is about 44% currently. As the global geriatric population increases, prevalence of conditions such as diabetes, cardiovascular problems, cancers and asthma are bound to rise. So , pharmaceutical companies are accelerating their research to develop effective treatments by using microbial products. However, low quality producers operating from unknown locations impedes the growth of the market over the forecast period of 2020-2027. Also, Opportunity is increasing demand for high quality reagents for producing medicines so the adoption & demand for Microbial Therapeutic Products is likely to increase.

The regional analysis of global Microbial Therapeutic Product is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. US is the leading/significant region across the world in terms of market share owing to the increasing expenditure on healthcare and per capita consumption of microbial products. Whereas, Europe is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising disposable income and rising consumption patterns would create lucrative growth prospects for the Microbial Therapeutic Products across Europe.

Major market player included in this report are:
Amgen Inc.
Merck & Co.,Inc.
Valent BioSciences Corp.
GlaxoSmithKline plc
Pfizer Inc.
bioMérieux SA
Ajinomoto Co.Inc.
Sanofi S.A
Novartis AG
NovaDigm Therapeutics

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Source:
Bacteria
Fungi

By Application:
Metabolic Disorders
Haematological Disorders
Oncology
Immunological Disorders

By End User:
Hospitals
Pharmaceuticals & Biopharmaceutical Companies
Research & Academic Institutions

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Microbial Therapeutic Products in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Microbial Therapeutic Market, by Region, 2018-2027 (USD Billion)
1.2.2. Microbial Therapeutic Market, by Source, 2018-2027 (USD Billion)
1.2.3. Microbial Therapeutic Market, by Application, 2018-2027 (USD Billion)
1.2.4. Microbial Therapeutic Market, by End user, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Microbial Therapeutic Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Microbial Therapeutic Market Dynamics
3.1. Microbial Therapeutic Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Microbial Therapeutic Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Microbial Therapeutic Market, by Source
5.1. Market Snapshot
5.2. Global Microbial Therapeutic Market by Source, Performance - Potential Analysis
5.3. Global Microbial Therapeutic Market Estimates & Forecasts by Source 2017-2027 (USD Billion)
5.4. Microbial Therapeutic Market, Sub Segment Analysis
5.4.1. Bacteria
5.4.2. Fungi
Chapter 6. Global Microbial Therapeutic Market, by Application
6.1. Market Snapshot
6.2. Global Microbial Therapeutic Market by Application, Performance - Potential Analysis
6.3. Global Microbial Therapeutic Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Microbial Therapeutic Market, Sub Segment Analysis
6.4.1. Metabolic Disorders
6.4.2. Haematological Disorders
6.4.3. Oncology
6.4.4. Immunological Disorders
Chapter 7. Global Microbial Therapeutic Market, by End user

7.1. Market Snapshot
7.2. Global Microbial Therapeutic Market by End user, Performance - Potential Analysis
7.3. Global Microbial Therapeutic Market Estimates & Forecasts by End user 2017-2027 (USD Billion)
7.4. Microbial Therapeutic Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Pharmaceuticals & Biopharmaceutical Companies
7.4.3. Research & Academic Institutions
Chapter 8. Global Microbial Therapeutic Market, Regional Analysis
8.1. Microbial Therapeutic Market, Regional Market Snapshot
8.2. North America Microbial Therapeutic Market
8.2.1. U.S. Microbial Therapeutic Market
8.2.1.1. Source breakdown estimates & forecasts, 2017-2027
8.2.1.2. Application breakdown estimates & forecasts, 2017-2027
8.2.1.3. End user breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Microbial Therapeutic Market
8.3. Europe Microbial Therapeutic Market Snapshot
8.3.1. U.K. Microbial Therapeutic Market
8.3.2. Germany Microbial Therapeutic Market
8.3.3. France Microbial Therapeutic Market
8.3.4. Spain Microbial Therapeutic Market
8.3.5. Italy Microbial Therapeutic Market
8.3.6. Rest of Europe Microbial Therapeutic Market
8.4. Asia-Pacific Microbial Therapeutic Market Snapshot
8.4.1. China Microbial Therapeutic Market
8.4.2. India Microbial Therapeutic Market
8.4.3. Japan Microbial Therapeutic Market
8.4.4. Australia Microbial Therapeutic Market
8.4.5. South Korea Microbial Therapeutic Market
8.4.6. Rest of Asia Pacific Microbial Therapeutic Market
8.5. Latin America Microbial Therapeutic Market Snapshot
8.5.1. Brazil Microbial Therapeutic Market
8.5.2. Mexico Microbial Therapeutic Market
8.6. Rest of The World Microbial Therapeutic Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Amgen Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Merck & Co.,Inc.
9.2.3. Valent BioSciences Corp.
9.2.4. GlaxoSmithKline plc
9.2.5. Pfizer Inc.
9.2.6. BioMérieux SA
9.2.7. Ajinomoto Co.Inc.
9.2.8. Sanofi S.A
9.2.9. Novartis AG
9.2.10. NovaDigm Therapeutics
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research AssumptionList of Tables
TABLE 1. Global Microbial Therapeutic market, report scope
TABLE 2. Global Microbial Therapeutic market estimates & forecasts by Region 2017-2027 (USD Billion)
TABLE 3. Global Microbial Therapeutic market estimates & forecasts by Source 2017-2027 (USD Billion)
TABLE 4. Global Microbial Therapeutic market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 5. Global Microbial Therapeutic market estimates & forecasts by End user 2017-2027 (USD Billion)
TABLE 6. Global Microbial Therapeutic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Microbial Therapeutic market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Microbial Therapeutic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Microbial Therapeutic market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Microbial Therapeutic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Microbial Therapeutic market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Microbial Therapeutic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Microbial Therapeutic market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Microbial Therapeutic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Microbial Therapeutic market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. U.S. Microbial Therapeutic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. U.S. Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 18. U.S. Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 19. Canada Microbial Therapeutic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Canada Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 21. Canada Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 22. UK Microbial Therapeutic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 23. UK Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. UK Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 25. Germany Microbial Therapeutic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 26. Germany Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. Germany Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 28. RoE Microbial Therapeutic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 29. RoE Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. RoE Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 31. China Microbial Therapeutic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 32. China Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. China Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 34. India Microbial Therapeutic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 35. India Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. India Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 37. Japan Microbial Therapeutic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 38. Japan Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. Japan Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 40. RoAPAC Microbial Therapeutic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 41. RoAPAC Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. RoAPAC Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 43. Brazil Microbial Therapeutic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 44. Brazil Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. Brazil Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 46. Mexico Microbial Therapeutic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 47. Mexico Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. Mexico Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 49. RoLA Microbial Therapeutic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 50. RoLA Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. RoLA Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 52. Row Microbial Therapeutic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 53. Row Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Row Microbial Therapeutic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Microbial Therapeutic market
TABLE 56. List of primary sources, used in the study of global Microbial Therapeutic market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates consideredList of figures
FIG 1. Global Microbial Therapeutic market, research methodology
FIG 2. Global Microbial Therapeutic market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Microbial Therapeutic market, key trends 2019
FIG 5. Global Microbial Therapeutic market, growth prospects 2020-2027
FIG 6. Global Microbial Therapeutic market, porters 5 force model
FIG 7. Global Microbial Therapeutic market, pest analysis
FIG 8. Global Microbial Therapeutic market, value chain analysis
FIG 9. Global Microbial Therapeutic market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Microbial Therapeutic market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Microbial Therapeutic market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Microbial Therapeutic market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Microbial Therapeutic market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Microbial Therapeutic market, regional snapshot 2017 & 2027
FIG 15. North America Microbial Therapeutic market 2017 & 2027 (USD Billion)
FIG 16. Europe Microbial Therapeutic market 2017 & 2027 (USD Billion)
FIG 17. Asia pacific Microbial Therapeutic market 2017 & 2027 (USD Billion)
FIG 18. Latin America Microbial Therapeutic market 2017 & 2027 (USD Billion)
FIG 19. Global Microbial Therapeutic market, company market share analysis (2019)

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+